- Home
- APLE vs MLTX Comparison
APLE vs MLTX Comparison
Compare APLE & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLE | MLTX |
|---|---|---|
| Founded | 2007 | 2021 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 972.7M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | APLE | MLTX |
|---|---|---|
| Price | $12.04 | $13.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | $14.17 | ★ $36.33 |
| AVG Volume (30 Days) | ★ 2.6M | 1.7M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | ★ 8.35% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $1,418,986,000.00 | N/A |
| Revenue This Year | $0.53 | N/A |
| Revenue Next Year | $2.22 | N/A |
| P/E Ratio | $16.44 | ★ N/A |
| Revenue Growth | ★ 0.57 | N/A |
| 52 Week Low | $10.44 | $5.95 |
| 52 Week High | $16.02 | $62.75 |
Technical Indicators
Market Signals| Indicator | APLE | MLTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.45 | 49.63 |
| Support Level | $11.90 | $13.32 |
| Resistance Level | $12.19 | $14.12 |
| Average True Range (ATR) | 0.21 | 0.77 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 59.07 | 32.45 |
Price Performance
Historical ComparisonAbout APLE Apple Hospitality REIT Inc.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.